CLINICAL_TRIALS
trial_result
· 2017-06-14
Clinical Trial Update: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers [Phase 3]
Summary
A Phase 3 trial comparing pexiganan to placebo for mild diabetic foot infections has completed. Results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dipexium Pharmaceuticals, Inc. | Conditions: Diabetic Foot Infection | Phase 3 | Status: COMPLETED | Results posted: 2017-06-14